Emicizumab should be prescribed independent of immune tolerance induction

Autor Le Quellec, Sandra, Negrier, Claude
Vydáno v Blood Adv (2018)

Dose tailoring of human cell line‐derived recombinant factor VIII simoctocog alfa: Using a limited sampling strategy in patients with severe haemophilia A

Autor Delavenne, Xavier, Dargaud, Yesim, Ollier, Edouard, Négrier, Claude
Vydáno v Br J Clin Pharmacol (2019)

Evaluation of early musculoskeletal disease in patients with haemophilia: results from an expert consensus

Autor Seuser, Axel, Djambas Khayat, Claudia, Negrier, Claude, Sabbour, Adly, Heijnen, Lily
Vydáno v Blood Coagul Fibrinolysis (2018)

Emerging Immunogenicity and Genotoxicity Considerations of Adeno-Associated Virus Vector Gene Therapy for Hemophilia

Autor Monahan, Paul E., Négrier, Claude, Tarantino, Michael, Valentino, Leonard A., Mingozzi, Federico
Vydáno v J Clin Med (2021)

Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives

Autor Young, Guy, Sørensen, Benny, Dargaud, Yesim, Negrier, Claude, Brummel-Ziedins, Kathleen, Key, Nigel S.
Vydáno 2013

Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab

Autor Dargaud, Yesim, Lienhart, Anne, Janbain, Maissaa, Le Quellec, Sandra, Enjolras, Nathalie, Negrier, Claude
Vydáno v Haematologica (2018)

Impaired factor XIII activation in patients with congenital afibrinogenemia

Autor Bridey, Françoise, Négrier, Claude, Duval, Cedric, Ariëns, Robert, de Moerloose, Philippe, Casini, Alessandro
Vydáno v Haematologica (2019)

Reccurrent F8 Intronic Deletion Found in Mild Hemophilia A Causes Alu Exonization

Autor Jourdy, Yohann, Janin, Alexandre, Fretigny, Mathilde, Lienhart, Anne, Négrier, Claude, Bozon, Dominique, Vinciguerra, Christine
Vydáno v Am J Hum Genet (2018)

Origins, Development, Current Challenges and Future Directions with Activated Prothrombin Complex Concentrate for the Treatment of Patients with Congenital Haemophilia with Inhibit...

Autor Brackmann, Hans H., Schramm, Wolfgang, Oldenburg, Johannes, Cano, Viridiana, Turecek, Peter L., Négrier, Claude
Vydáno v Hamostaseologie (2020)

MDA-9/Syntenin Is Essential for Factor VIIa-induced Signaling, Migration, and Metastasis in Melanoma Cells

Autor Aissaoui, Hanaa, Prévost, Célia, Boucharaba, Ahmed, Sanhadji, Kamel, Bordet, Jean-Claude, Négrier, Claude, Boukerche, Habib
Vydáno v J Biol Chem (2015)

MDA-9/Syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cells.

Autor Aissaoui, Hanaa, Prévost, Célia, Boucharaba, Ahmed, Sanhadji, Kamel, Bordet, Jean-Claude, Négrier, Claude, Boukerche, Habib
Vydáno v J Biol Chem (2015)

Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis

Autor Mancuso, Maria Elisa, Reding, Mark T., Negrier, Claude, Kerlin, Bryce A., Rangarajan, Savita, Simpson, Mindy L.
Vydáno v Thromb Haemost (2021)

Alpha Cyano-4-Hydroxy-3-Methoxycinnamic Acid Inhibits Proliferation and Induces Apoptosis in Human Breast Cancer Cells

Autor Hamdan, Lamia, Arrar, Zoheir, Al Muataz, Yacoub, Suleiman, Lutfi, Négrier, Claude, Mulengi, Joseph Kajima, Boukerche, Habib
Vydáno 2013

Why patients with THBD c.1611C>A (p.Cys537X) nonsense mutation have high levels of soluble thrombomodulin?

Autor Jourdy, Yohann, Enjolras, Nathalie, Le Quellec, Sandra, Bordet, Jean Claude, Négrier, Claude, Vinciguerra, Christine, Dargaud, Yesim
Vydáno v PLoS One (2017)

Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients

Autor Santagostino, Elena, Negrier, Claude, Klamroth, Robert, Tiede, Andreas, Pabinger-Fasching, Ingrid, Voigt, Christine, Jacobs, Iris, Morfini, Massimo
Vydáno 2012

A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal

Autor Kerebel, Delphine, Joly, Luc-Marie, Honnart, Didier, Schmidt, Jeannot, Galanaud, Damien, Negrier, Claude, Kursten, Friedrich, Coriat, Pierre
Vydáno 2013

Global Post-Authorization Safety Surveillance Study: real-world data on prophylaxis and on-demand treatment using FEIBA (an activated prothrombin complex concentrate)

Autor Negrier, Claude, Voisin, Sophie, Baghaei, Fariba, Numerof, Robert, Novack, Aaron, Doralt, Jennifer E., Romanov, Vadim, Gringeri, Alessandro
Vydáno v Blood Coagul Fibrinolysis (2016)

Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia A with Factor VIII Inhibitors: HAVEN 1 Study

Autor Schmitt, Christophe, Adamkewicz, Joanne I., Xu, Jin, Petry, Claire, Catalani, Olivier, Young, Guy, Negrier, Claude, Callaghan, Michael U., Levy, Gallia G.
Vydáno v Thromb Haemost (2021)

Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐COV2 associated thrombosis

Autor Nougier, Christophe, Benoit, Remi, Simon, Marie, Desmurs‐Clavel, Helene, Marcotte, Guillaume, Argaud, Laurent, David, Jean Stephane, Bonnet, Aurelie, Negrier, Claude, Dargaud, Yesim
Vydáno v J Thromb Haemost (2020)

Characterization of an autosomal dominant bleeding disorder caused by a thrombomodulin mutation

Autor Dargaud, Yesim, Scoazec, Jean Yves, Wielders, Simone J. H., Trzeciak, Christine, Hackeng, Tilman M., Négrier, Claude, Hemker, H. Coenraad, Lindhout, Theo, Castoldi, Elisabetta
Vydáno v Blood (2015)